These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


113 related items for PubMed ID: 395082

  • 1. Closed-loop system in evaluation of insulin infusion rates for an open-loop system.
    Kølendorf K, Christiansen JS, Svendsen PA, Bojsen J.
    Horm Metab Res Suppl; 1979; (8):205-6. PubMed ID: 395082
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Insulin treatment and state of control before, during, and after connection to a glucose controlled insulin infusion system (Biostator).
    Christiansen JS, Svendsen PA, Deckert T.
    Horm Metab Res Suppl; 1979; (8):131-4. PubMed ID: 395069
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The external artificial pancreas: an instrument to induce remissions in severe recent juvenile diabetes. Comparison with a preprogrammed insulin infusion system.
    Mirouze J, Selam JL, Pham TC, Orsetti A.
    Horm Metab Res Suppl; 1979; (8):141-5. PubMed ID: 395071
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Use of glucose-controlled insulin infusion system for improvement of subcutaneous insulin regimen.
    Irsigler K, Kritz H, Kaspar L, Brändle J, Franetzki M.
    Horm Metab Res Suppl; 1979; (8):134-40. PubMed ID: 395070
    [Abstract] [Full Text] [Related]

  • 11. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
    Beyer J, Wolf E, Cordes U, Hassingen W.
    Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV.
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [Abstract] [Full Text] [Related]

  • 16. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
    Lambert AE, Buysschaert M, Lambotte L.
    Horm Metab Res Suppl; 1979 May; (8):120-7. PubMed ID: 395067
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influence of cortisol circadian variations on insulin need and delivery in insulin-dependent diabetics. Assessment by the artificial beta cell.
    Altomare E, Moulin JP, Tavares S, Bourelly N, Lassmann V, Vague P.
    Horm Metab Res Suppl; 1979 May; (8):110-5. PubMed ID: 395065
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.